Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088205
Status:
COMPLETED
Last Update Posted:
2020-07-01
First Post:
2004-07-22
Brief Title:
Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-22
First Submit QC Date:
July 22 2004
Study First Post Date:
2004-07-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-07-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2009-06-10
Disp First Submit QC Date:
October 5 2009
Disp First Post Date:
2009-10-07
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-06-09
Last Update Post Date:
2020-07-01
Last Update Post Date Type:
ACTUAL